Type
. Immunologic unresponsiveness in leprosy is mediated by modulation of E-receptor. Immunology letters. 1987;15(3):199-204.
Type
. Therapeutic response of modern chemotherapy in hansenology. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1987;6(2 Suppl):358-9.
Type
. Impact of leprosy on the family and intimate relationships. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1987;6(2 Suppl):356-7.
Type
. The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes. Immunology. 1987;61(2):125-9.
Type
. Surgical management in ocular leprosy. Indian journal of ophthalmology. 1987;35(3):153-7.
Type
. [Treatment of patients with temporomandibular joint pathology developing in lepromatous leprosy]. Stomatologiia. 1987;66(3):41-3.
Type
. [Assessment and treatment of the dry eye in Hansen's disease]. Revista brasileira de enfermagem. 1987;40(2-3):118-22.
Type
. Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice. Antimicrobial agents and chemotherapy. 1987;31(4):671-2.
Type
. [Skin diseases in Sierra Leone]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1987;38(3):146-54.
Type
. Hypercalcaemia and elevated 1,25-dihydroxy-vitamin D3 levels in a patient with multibacillary leprosy and a type I leprosy reaction. The New Zealand medical journal. 1987;100(817):86.